Nothing Special   »   [go: up one dir, main page]

Biffi et al., 2013 - Google Patents

Occurrence of phrenic nerve stimulation in cardiac resynchronization therapy patients: the role of left ventricular lead type and placement site

Biffi et al., 2013

View HTML
Document ID
13228283947409206432
Author
Biffi M
Exner D
Crossley G
Ramza B
Coutu B
Tomassoni G
Kranig W
Li S
Kristiansen N
Voss F
Publication year
Publication venue
Europace

External Links

Snippet

Aims Unwanted phrenic nerve stimulation (PNS) has been reported in∼ 1 in 4 patients undergoing left ventricular (LV) pacing. The occurrence of PNS over mid-term follow-up and the significance of PNS are less certain. Methods and results Data from 1307 patients …
Continue reading at academic.oup.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39—Heart defibrillators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/08—Arrangements or circuits for monitoring, protecting, controlling or indicating

Similar Documents

Publication Publication Date Title
Biffi et al. Occurrence of phrenic nerve stimulation in cardiac resynchronization therapy patients: the role of left ventricular lead type and placement site
Forleo et al. Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study
Sperzel et al. First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead
Erkapic et al. Insulation defects of thin high‐voltage ICD leads: an underestimated problem?
Nowak et al. Do gender differences exist in pacemaker implantation?—results of an obligatory external quality control program
Migliore et al. Intermuscular two‐incision technique for subcutaneous implantable cardioverter defibrillator implantation: results from a multicenter registry
Friedman et al. A prospective randomized trial of single-or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention
Seifert et al. Influence of pacing configurations, body mass index, and position of coronary sinus lead on frequency of phrenic nerve stimulation and pacing thresholds under cardiac resynchronization therapy
Silvetti et al. Single-centre experience on endocardial and epicardial pacemaker system function in neonates and infants
Biffi et al. Left ventricular lead stabilization to retain cardiac resynchronization therapy at long term: when is it advisable?
Tilz et al. Management of ventricular tachycardia in the ablation era: results of the European Heart Rhythm Association Survey
Boersma et al. Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication
De Leon et al. Adopting permanent His bundle pacing: learning curves and medium-term outcomes
Oloriz et al. Defining the outcome of ventricular tachycardia ablation: timing and value of programmed ventricular stimulation
Safak et al. Clinical efficacy and safety of an implantable cardioverter‐defibrillator lead with a floating atrial sensing dipole
Expósito et al. Primary prevention implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator in elderly patients: results of a Spanish multicentre study
Adelstein et al. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older
Ahsan et al. An 8-year single-centre experience of cardiac resynchronisation therapy: procedural success, early and late complications, and left ventricular lead performance
Al-Hijji et al. Outcomes of lead extraction without subsequent device reimplantation
Piccini et al. Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing
Erath et al. Clinical outcomes after implantation of quadripolar compared to bipolar left ventricular leads in patients undergoing cardiac resynchronization therapy: a systematic review and meta-analysis
Ząbek et al. Mechanical extraction of implantable cardioverter-defibrillator leads with a dwell time of more than 10 years: insights from a single high-volume centre
Biffi et al. The OPTI-MIND study: a prospective, observational study of pacemaker patients according to pacing modality and primary indications
Lopez Implantable cardioverter defibrillator lead placement in the middle cardiac vein after tricuspid valve surgery
Sjöblom et al. Efficacy of primary preventive ICD therapy in an unselected population of patients with reduced left ventricular ejection fraction